Rua Bioscience Limited — Share Issue/Capital Change 2025

Jun 9, 2025

Capital Change Notice

==> picture [78 x 33] intentionally omitted <==

Section 1: Issuer information
Name of issuer	Rua Bioscience Limited
NZX ticker code	RUA
Class of financial product	Ordinary shares
ISIN (If unknown, check on NZX website)	NZRUAE0004S1
Currency	NZ$
Section 2: Capital change details
Number issued/acquired/redeemed	162,145 warrants
Nominal value (if any)	N/A
Issue/acquisition/redemption price per security	$0.015
Nature of the payment (for example, cash or otherconsideration)	No consideration is payable forthe warrants. Cashconsideration of $0.015 pershare is payable on exercise ofthe warrants
Amount paid up (if not in full)	Paid in full on exercise of thewarrant
Percentage of total class of Financial Productsissued/acquired/redeemed/ (calculated on the number ofFinancial Products of the Class, excluding any Treasury Stock,in existence)1	Rua currently has 223,648,012ordinary shares on issue.This issue of warrantsrepresents 0.073% of the totalordinary shares on issue(being the percentage shouldall warrants vest and beexercised).
For an issue of Convertible Financial Products or Options, theprincipal terms of Conversion (for example the Conversionprice and Conversion date and the ranking of the FinancialProduct in relation to other Classes of Financial Product) or theOption (for example, the exercise price and exercise date)	Vesting will occur 12 monthsfollowing theIssue/Commencement Dateafter which the warrants areable to be converted/exercisedto ordinary shares up to theMaturity Date which is 3 yearsfollowing theIssue/Commencement Date.
Reason for issue/acquisition/redemption and specific authorityfor issue/acquisition/redemption/ (the reason for change mustbe identified here)	Issue of warrants as per BoardResolution regarding debtfacility arrangement.
Total number of Financial Products of the Class after theissue/acquisition/redemption/Conversion (excluding TreasuryStock) and the total number of Financial Products of the Classheld as Treasury Stock after the issue/acquisition/redemption.	Total ordinary shares on issue:223,648,012 ordinary sharesTotal warrants on issue:301,925 warrants

1 The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

In the case of an acquisition of shares, whether those sharesare to be held as treasury stock	N/A
Specific authority for the issue, acquisition, or redemption,including a reference to the rule pursuant to which the issue,acquisition, or redemption is made	Board resolution dated 14 May2025 and Listing Rule 4.5.1
Terms or details of the issue, acquisition, or redemption (forexample: restrictions, escrow arrangements)	The warrants are issued aspart of a Debt Facilityarrangement.Vesting will occur 12 monthsfollowing theIssue/Commencement Dateafter which the warrants areable to be converted toordinary shares up to theMaturity Date which is 3 yearsfollowing theIssue/Commencement Date.New ordinary shares issuedupon exercise of the warrantswill rank equally in all respectswith the ordinary sharesalready on issue.
Date of issue/acquisition/redemption	06/06/2025
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement	Paul Naske
Contact person for this announcement	Paul Naske
Contact phone number	021 445 154
Contact email address	Paul.naske@ruabio.com
Date of release through MAP	09/06/2025